A Systematic Review of Cost-Effectiveness Analyses for Hepatocellular Carcinoma Treatment View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2021-08-24

AUTHORS

Sydney C. Yuen, Adaeze Q. Amaefule, Hannah H. Kim, Breanna-Verissa Owoo, Emily F. Gorman, T. Joseph Mattingly

ABSTRACT

BackgroundHepatocellular carcinoma (HCC) is associated with significant financial burden for patients and payers. The objective of this study was to review economic models to identify, evaluate, and compare cost-effectiveness estimates for HCC treatments.MethodsA systematic search of the PubMed, Embase, and Cochrane Library databases to identify economic evaluations was performed and studies that modeled treatments for HCC reporting costs and cost effectiveness were included. Risk of bias was assessed qualitatively, considering costing approach, reported study perspective, and funding received. Intervention costs were adjusted to 2021 US dollars for comparison. For studies reporting quality-adjusted life-years (QALYs), we conducted analyses stratified by comparison type to assess cost effectiveness at the time of the analysis.ResultsA total of 27 studies were included. Non-curative versus non-curative therapy comparisons were used in 20 (74.1%) studies, curative versus curative comparisons were used in 5 (18.5%) studies, and curative versus non-curative comparisons were used in 2 (7.4%) studies. Therapy effectiveness was estimated using a QALY measure in 20 (74.1%) studies, while 7 (25.9%) studies only assessed life-years gained (LYG). A health sector perspective was used in 26 (96.3%) of the evaluations, with only 1 study including costs beyond this perspective. Median intervention cost was $53,954 (range $4550–$4,760,835), with a median incremental cost of $6546 (range − $72,441 to $1,279,764). In cost-utility analyses, 11 (55%) studies found the intervention cost effective using a $100,000/QALY threshold at the time of the study, with an incremental cost-effectiveness ratio (ICER) ranging from − $1,176,091 to $1,152,440 when inflated to 2021 US dollars.ConclusionThe majority of HCC treatments were found to be cost effective, but with significant variation and with few studies considering indirect costs. Standards for value assessment for HCC treatments may help improve consistency and comparability. More... »

PAGES

1-11

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s41669-021-00298-z

DOI

http://dx.doi.org/10.1007/s41669-021-00298-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1140619010

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34427897


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/14", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Economics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1402", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Applied Economics", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, 21201, Baltimore, MD, USA", 
          "id": "http://www.grid.ac/institutes/grid.411024.2", 
          "name": [
            "University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, 21201, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yuen", 
        "givenName": "Sydney C.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, 21201, Baltimore, MD, USA", 
          "id": "http://www.grid.ac/institutes/grid.411024.2", 
          "name": [
            "University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, 21201, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Amaefule", 
        "givenName": "Adaeze Q.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, 21201, Baltimore, MD, USA", 
          "id": "http://www.grid.ac/institutes/grid.411024.2", 
          "name": [
            "University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, 21201, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Hannah H.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, 21201, Baltimore, MD, USA", 
          "id": "http://www.grid.ac/institutes/grid.411024.2", 
          "name": [
            "University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, 21201, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Owoo", 
        "givenName": "Breanna-Verissa", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Health Sciences and Human Services Library, University of Maryland, Baltimore, MD, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Health Sciences and Human Services Library, University of Maryland, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gorman", 
        "givenName": "Emily F.", 
        "id": "sg:person.011430775014.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011430775014.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, 21201, Baltimore, MD, USA", 
          "id": "http://www.grid.ac/institutes/grid.411024.2", 
          "name": [
            "University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, 21201, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mattingly", 
        "givenName": "T. Joseph", 
        "id": "sg:person.01112262523.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112262523.40"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00268-015-2987-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017830149", 
          "https://doi.org/10.1007/s00268-015-2987-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12885-017-3892-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100150847", 
          "https://doi.org/10.1186/s12885-017-3892-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40273-018-0672-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104125195", 
          "https://doi.org/10.1007/s40273-018-0672-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13014-016-0644-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013321936", 
          "https://doi.org/10.1186/s13014-016-0644-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00535-019-01554-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1112260059", 
          "https://doi.org/10.1007/s00535-019-01554-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40273-020-00942-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1129536135", 
          "https://doi.org/10.1007/s40273-020-00942-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40271-019-00378-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1119862567", 
          "https://doi.org/10.1007/s40271-019-00378-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12876-020-01241-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1126868676", 
          "https://doi.org/10.1186/s12876-020-01241-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12962-018-0112-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1105975843", 
          "https://doi.org/10.1186/s12962-018-0112-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41575-019-0186-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1120492567", 
          "https://doi.org/10.1038/s41575-019-0186-y"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-08-24", 
    "datePublishedReg": "2021-08-24", 
    "description": "BackgroundHepatocellular carcinoma (HCC) is associated with significant financial burden for patients and payers. The objective of this study was to review economic models to identify, evaluate, and compare cost-effectiveness estimates for HCC treatments.MethodsA systematic search of the PubMed, Embase, and Cochrane Library databases to identify economic evaluations was performed and studies that modeled treatments for HCC reporting costs and cost effectiveness were included. Risk of bias was assessed qualitatively, considering costing approach, reported study perspective, and funding received. Intervention costs were adjusted to 2021 US dollars for comparison. For studies reporting quality-adjusted life-years (QALYs), we conducted analyses stratified by comparison type to assess cost effectiveness at the time of the analysis.ResultsA total of 27 studies were included. Non-curative versus non-curative therapy comparisons were used in 20 (74.1%) studies, curative versus curative comparisons were used in 5 (18.5%) studies, and curative versus non-curative comparisons were used in 2 (7.4%) studies. Therapy effectiveness was estimated using a QALY measure in 20 (74.1%) studies, while 7 (25.9%) studies only assessed life-years gained (LYG). A health sector perspective was used in 26 (96.3%) of the evaluations, with only 1 study including costs beyond this perspective. Median intervention cost was $53,954 (range $4550\u2013$4,760,835), with a median incremental cost of $6546 (range \u2212\u00a0$72,441 to $1,279,764). In cost-utility analyses, 11 (55%) studies found the intervention cost effective using a $100,000/QALY threshold at the time of the study, with an incremental cost-effectiveness ratio (ICER) ranging from \u2212\u00a0$1,176,091 to $1,152,440 when inflated to 2021 US dollars.ConclusionThe majority of HCC treatments were found to be cost effective, but with significant variation and with few studies considering indirect costs. Standards for value assessment for HCC treatments may help improve consistency and comparability.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s41669-021-00298-z", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1284515", 
        "issn": [
          "2509-4262", 
          "2509-4254"
        ], 
        "name": "PharmacoEconomics - Open", 
        "type": "Periodical"
      }
    ], 
    "keywords": [
      "incremental cost-effectiveness ratio", 
      "intervention costs", 
      "US dollars", 
      "cost-effectiveness estimates", 
      "cost-utility analysis", 
      "cost-effectiveness analysis", 
      "health sector perspective", 
      "cost-effectiveness ratio", 
      "QALY measures", 
      "median incremental cost", 
      "economic model", 
      "reporting costs", 
      "cost effectiveness", 
      "economic evaluation", 
      "QALY threshold", 
      "sector perspective", 
      "incremental cost", 
      "indirect costs", 
      "value assessment", 
      "financial burden", 
      "HCC treatment", 
      "study perspective", 
      "dollars", 
      "cost", 
      "significant financial burden", 
      "Cochrane Library databases", 
      "risk of bias", 
      "hepatocellular carcinoma treatment", 
      "ResultsA total", 
      "carcinoma treatment", 
      "BackgroundHepatocellular carcinoma", 
      "ConclusionThe majority", 
      "Library databases", 
      "therapy effectiveness", 
      "systematic review", 
      "payers", 
      "therapy comparison", 
      "funding", 
      "systematic search", 
      "perspective", 
      "treatment", 
      "estimates", 
      "comparability", 
      "measures", 
      "EMBASE", 
      "analysis", 
      "patients", 
      "carcinoma", 
      "study", 
      "PubMed", 
      "bias", 
      "model", 
      "burden", 
      "comparison type", 
      "risk", 
      "total", 
      "evaluation", 
      "effectiveness", 
      "objective", 
      "review", 
      "majority", 
      "significant variation", 
      "standards", 
      "assessment", 
      "approach", 
      "comparison", 
      "database", 
      "time", 
      "threshold", 
      "consistency", 
      "search", 
      "ratio", 
      "types", 
      "variation", 
      "HCC reporting costs", 
      "non-curative therapy comparisons", 
      "curative comparisons", 
      "non-curative comparisons", 
      "Median intervention cost"
    ], 
    "name": "A Systematic Review of Cost-Effectiveness Analyses for Hepatocellular Carcinoma Treatment", 
    "pagination": "1-11", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1140619010"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s41669-021-00298-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34427897"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s41669-021-00298-z", 
      "https://app.dimensions.ai/details/publication/pub.1140619010"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T19:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_916.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s41669-021-00298-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00298-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00298-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00298-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00298-z'


 

This table displays all metadata directly associated to this object as RDF triples.

216 TRIPLES      22 PREDICATES      115 URIs      95 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s41669-021-00298-z schema:about anzsrc-for:11
2 anzsrc-for:1117
3 anzsrc-for:14
4 anzsrc-for:1402
5 schema:author N36ac63c1f78a401fbce6240fb405bf08
6 schema:citation sg:pub.10.1007/s00268-015-2987-7
7 sg:pub.10.1007/s00535-019-01554-0
8 sg:pub.10.1007/s40271-019-00378-7
9 sg:pub.10.1007/s40273-018-0672-z
10 sg:pub.10.1007/s40273-020-00942-2
11 sg:pub.10.1038/s41575-019-0186-y
12 sg:pub.10.1186/s12876-020-01241-y
13 sg:pub.10.1186/s12885-017-3892-2
14 sg:pub.10.1186/s12962-018-0112-0
15 sg:pub.10.1186/s13014-016-0644-4
16 schema:datePublished 2021-08-24
17 schema:datePublishedReg 2021-08-24
18 schema:description BackgroundHepatocellular carcinoma (HCC) is associated with significant financial burden for patients and payers. The objective of this study was to review economic models to identify, evaluate, and compare cost-effectiveness estimates for HCC treatments.MethodsA systematic search of the PubMed, Embase, and Cochrane Library databases to identify economic evaluations was performed and studies that modeled treatments for HCC reporting costs and cost effectiveness were included. Risk of bias was assessed qualitatively, considering costing approach, reported study perspective, and funding received. Intervention costs were adjusted to 2021 US dollars for comparison. For studies reporting quality-adjusted life-years (QALYs), we conducted analyses stratified by comparison type to assess cost effectiveness at the time of the analysis.ResultsA total of 27 studies were included. Non-curative versus non-curative therapy comparisons were used in 20 (74.1%) studies, curative versus curative comparisons were used in 5 (18.5%) studies, and curative versus non-curative comparisons were used in 2 (7.4%) studies. Therapy effectiveness was estimated using a QALY measure in 20 (74.1%) studies, while 7 (25.9%) studies only assessed life-years gained (LYG). A health sector perspective was used in 26 (96.3%) of the evaluations, with only 1 study including costs beyond this perspective. Median intervention cost was $53,954 (range $4550–$4,760,835), with a median incremental cost of $6546 (range − $72,441 to $1,279,764). In cost-utility analyses, 11 (55%) studies found the intervention cost effective using a $100,000/QALY threshold at the time of the study, with an incremental cost-effectiveness ratio (ICER) ranging from − $1,176,091 to $1,152,440 when inflated to 2021 US dollars.ConclusionThe majority of HCC treatments were found to be cost effective, but with significant variation and with few studies considering indirect costs. Standards for value assessment for HCC treatments may help improve consistency and comparability.
19 schema:genre article
20 schema:inLanguage en
21 schema:isAccessibleForFree true
22 schema:isPartOf sg:journal.1284515
23 schema:keywords BackgroundHepatocellular carcinoma
24 Cochrane Library databases
25 ConclusionThe majority
26 EMBASE
27 HCC reporting costs
28 HCC treatment
29 Library databases
30 Median intervention cost
31 PubMed
32 QALY measures
33 QALY threshold
34 ResultsA total
35 US dollars
36 analysis
37 approach
38 assessment
39 bias
40 burden
41 carcinoma
42 carcinoma treatment
43 comparability
44 comparison
45 comparison type
46 consistency
47 cost
48 cost effectiveness
49 cost-effectiveness analysis
50 cost-effectiveness estimates
51 cost-effectiveness ratio
52 cost-utility analysis
53 curative comparisons
54 database
55 dollars
56 economic evaluation
57 economic model
58 effectiveness
59 estimates
60 evaluation
61 financial burden
62 funding
63 health sector perspective
64 hepatocellular carcinoma treatment
65 incremental cost
66 incremental cost-effectiveness ratio
67 indirect costs
68 intervention costs
69 majority
70 measures
71 median incremental cost
72 model
73 non-curative comparisons
74 non-curative therapy comparisons
75 objective
76 patients
77 payers
78 perspective
79 ratio
80 reporting costs
81 review
82 risk
83 risk of bias
84 search
85 sector perspective
86 significant financial burden
87 significant variation
88 standards
89 study
90 study perspective
91 systematic review
92 systematic search
93 therapy comparison
94 therapy effectiveness
95 threshold
96 time
97 total
98 treatment
99 types
100 value assessment
101 variation
102 schema:name A Systematic Review of Cost-Effectiveness Analyses for Hepatocellular Carcinoma Treatment
103 schema:pagination 1-11
104 schema:productId N51fee5a9363a4e52894b7a621367d24a
105 N8c6e2a7805434d179a90163174aad638
106 Nc0206dba50ea4e4382a0c86365ac6538
107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1140619010
108 https://doi.org/10.1007/s41669-021-00298-z
109 schema:sdDatePublished 2022-01-01T19:03
110 schema:sdLicense https://scigraph.springernature.com/explorer/license/
111 schema:sdPublisher Ndbb32e279112446a8529e7c7e20b1713
112 schema:url https://doi.org/10.1007/s41669-021-00298-z
113 sgo:license sg:explorer/license/
114 sgo:sdDataset articles
115 rdf:type schema:ScholarlyArticle
116 N333ea7787c5046a49623910678542f17 schema:affiliation grid-institutes:grid.411024.2
117 schema:familyName Yuen
118 schema:givenName Sydney C.
119 rdf:type schema:Person
120 N35bb5155afda40fa82cf6e3284fc6d08 schema:affiliation grid-institutes:grid.411024.2
121 schema:familyName Owoo
122 schema:givenName Breanna-Verissa
123 rdf:type schema:Person
124 N36ac63c1f78a401fbce6240fb405bf08 rdf:first N333ea7787c5046a49623910678542f17
125 rdf:rest N6efe94d3d49945479e25720f41b60e5c
126 N4775c81dd63640c58bb4d3a8ad98d3bc rdf:first sg:person.01112262523.40
127 rdf:rest rdf:nil
128 N4c7e965f87424706bf4bd9d59ada8b71 schema:affiliation grid-institutes:grid.411024.2
129 schema:familyName Amaefule
130 schema:givenName Adaeze Q.
131 rdf:type schema:Person
132 N51fee5a9363a4e52894b7a621367d24a schema:name dimensions_id
133 schema:value pub.1140619010
134 rdf:type schema:PropertyValue
135 N5c8c1458404b48d080395b78fb12cbb9 rdf:first N6e1f98e4e6da4c2a8fc8e6f43d9591ff
136 rdf:rest Nd3c655a47ad543f2930cdbb4bf8687b0
137 N6e1f98e4e6da4c2a8fc8e6f43d9591ff schema:affiliation grid-institutes:grid.411024.2
138 schema:familyName Kim
139 schema:givenName Hannah H.
140 rdf:type schema:Person
141 N6efe94d3d49945479e25720f41b60e5c rdf:first N4c7e965f87424706bf4bd9d59ada8b71
142 rdf:rest N5c8c1458404b48d080395b78fb12cbb9
143 N8c6e2a7805434d179a90163174aad638 schema:name pubmed_id
144 schema:value 34427897
145 rdf:type schema:PropertyValue
146 Nc0206dba50ea4e4382a0c86365ac6538 schema:name doi
147 schema:value 10.1007/s41669-021-00298-z
148 rdf:type schema:PropertyValue
149 Nd3c655a47ad543f2930cdbb4bf8687b0 rdf:first N35bb5155afda40fa82cf6e3284fc6d08
150 rdf:rest Nfd64be42f7bc4a358714def4e6c9a8a1
151 Ndbb32e279112446a8529e7c7e20b1713 schema:name Springer Nature - SN SciGraph project
152 rdf:type schema:Organization
153 Nfd64be42f7bc4a358714def4e6c9a8a1 rdf:first sg:person.011430775014.10
154 rdf:rest N4775c81dd63640c58bb4d3a8ad98d3bc
155 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
156 schema:name Medical and Health Sciences
157 rdf:type schema:DefinedTerm
158 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
159 schema:name Public Health and Health Services
160 rdf:type schema:DefinedTerm
161 anzsrc-for:14 schema:inDefinedTermSet anzsrc-for:
162 schema:name Economics
163 rdf:type schema:DefinedTerm
164 anzsrc-for:1402 schema:inDefinedTermSet anzsrc-for:
165 schema:name Applied Economics
166 rdf:type schema:DefinedTerm
167 sg:journal.1284515 schema:issn 2509-4254
168 2509-4262
169 schema:name PharmacoEconomics - Open
170 rdf:type schema:Periodical
171 sg:person.01112262523.40 schema:affiliation grid-institutes:grid.411024.2
172 schema:familyName Mattingly
173 schema:givenName T. Joseph
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112262523.40
175 rdf:type schema:Person
176 sg:person.011430775014.10 schema:affiliation grid-institutes:None
177 schema:familyName Gorman
178 schema:givenName Emily F.
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011430775014.10
180 rdf:type schema:Person
181 sg:pub.10.1007/s00268-015-2987-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017830149
182 https://doi.org/10.1007/s00268-015-2987-7
183 rdf:type schema:CreativeWork
184 sg:pub.10.1007/s00535-019-01554-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112260059
185 https://doi.org/10.1007/s00535-019-01554-0
186 rdf:type schema:CreativeWork
187 sg:pub.10.1007/s40271-019-00378-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1119862567
188 https://doi.org/10.1007/s40271-019-00378-7
189 rdf:type schema:CreativeWork
190 sg:pub.10.1007/s40273-018-0672-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1104125195
191 https://doi.org/10.1007/s40273-018-0672-z
192 rdf:type schema:CreativeWork
193 sg:pub.10.1007/s40273-020-00942-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1129536135
194 https://doi.org/10.1007/s40273-020-00942-2
195 rdf:type schema:CreativeWork
196 sg:pub.10.1038/s41575-019-0186-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1120492567
197 https://doi.org/10.1038/s41575-019-0186-y
198 rdf:type schema:CreativeWork
199 sg:pub.10.1186/s12876-020-01241-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1126868676
200 https://doi.org/10.1186/s12876-020-01241-y
201 rdf:type schema:CreativeWork
202 sg:pub.10.1186/s12885-017-3892-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100150847
203 https://doi.org/10.1186/s12885-017-3892-2
204 rdf:type schema:CreativeWork
205 sg:pub.10.1186/s12962-018-0112-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105975843
206 https://doi.org/10.1186/s12962-018-0112-0
207 rdf:type schema:CreativeWork
208 sg:pub.10.1186/s13014-016-0644-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013321936
209 https://doi.org/10.1186/s13014-016-0644-4
210 rdf:type schema:CreativeWork
211 grid-institutes:None schema:alternateName Health Sciences and Human Services Library, University of Maryland, Baltimore, MD, USA
212 schema:name Health Sciences and Human Services Library, University of Maryland, Baltimore, MD, USA
213 rdf:type schema:Organization
214 grid-institutes:grid.411024.2 schema:alternateName University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, 21201, Baltimore, MD, USA
215 schema:name University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, 21201, Baltimore, MD, USA
216 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...